Related Experiment Video
Updated: Aug 7, 2026

10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Toxic epidermal necrolysis in Western Australia
1Department of Dermatology, Royal Perth Hospital, Western Australia, Australia. Lyndcrou@nero.rph.health.wa.gov.au
The Australasian Journal of Dermatology
|March 15, 2000
Summary
Toxic epidermal necrolysis (TEN) is a severe drug reaction with high mortality. This study found that systemic corticosteroids may reduce complications and death in TEN patients.
Area of Science:
- Dermatology
- Pharmacology
- Internal Medicine
Background:
- Toxic epidermal necrolysis (TEN) is a rare but severe, life-threatening mucocutaneous reaction.
- Mortality rates for TEN can be as high as 33%.
Purpose of the Study:
- To analyze cases of TEN treated at Royal Perth Hospital over a 20-year period.
- To identify risk factors for mortality and evaluate treatment efficacy.
Main Methods:
- Retrospective analysis of medical records for all TEN cases.
- Data collected included patient demographics, associated medications, and outcomes.
Main Results:
- Twelve patients (23-73 years; 2:1 female:male ratio) were identified.
- Commonly associated medications included antibiotics, anticonvulsants, and allopurinol.
- Mortality was 33%, with sepsis and organ failure as primary causes. Advanced age and comorbidities were risk factors for death.
Conclusions:
- Systemic corticosteroids were associated with a lower mortality rate (1/6 deaths) and fewer complications.
- Corticosteroid treatment may be beneficial in managing toxic epidermal necrolysis.
Related Concept Videos
Necrosis
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Cellular Injury IV: Necrosis
Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...

